Wednesday, March 17, 2027 - 9:00 AM
to Friday, March 19, 2027 - 5:15 PM
9:00 AM - 5:15 PM See all dates and Times
Liquid biopsy remains one of the largest investments in oncology drug development. If your clinical program is not acting on every signal it generates, you could be leaving significant value and budget on the table.
The 11th Liquid Biopsy for Precision Oncology Summit West Coast will spotlight how industry-leading teams are closing that gap, from first-in-human dose findings to MRD endpoints, resistance monitoring and patient access.
The field is evolving faster than ever; in the last year, SERENA-6 and IMvigor011 have transformed how sponsors design trials, assays have become increasingly sensitive and specific, and the vendor landscape is consolidating. Failing to keep pace with these advancements means that your ctDNA strategy risks already being out of date.
Take your place alongside AstraZeneca, Genentech, Amgen, Pfizer, Johnson & Johnson, Regeneron, AbbVie, Takeda and more across two focused tracks of live program data, panels and one-to-one meetings, to leave knowing exactly what to change on Monday.
Event Links
Website: https://go.evvnt.com/3898292-0
Tickets: https://go.evvnt.com/3898292-2
Brochure: https://go.evvnt.com/3898292-3
